MedPath

Effect of Dynamic Neuromuscular Stabilization and Neurodevelopmental Therapy on trunk control and cardiopulmonary function in hemiplegic stroke.

Not Applicable
Completed
Conditions
Health Condition 1: I699- Sequelae of unspecified cerebrovascular diseases
Registration Number
CTRI/2022/01/039250
Lead Sponsor
Raghumahanti Raghuveer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.Subjects with age >18 years diagnosed as sub-acute hemiplegia between 4 weeks to 6 months following a first-time stroke.

2.Haemorrhagic or ischemic stroke involving one hemisphere and diagnosed clinically and radiologically with a CT scan.

3.Patient having Mini-Mental State Examination (MMSE) score >= 24

4.Patients with trunk impairment following stroke with scores < 23 on the Trunk Impairment Scale.

5.Patient having Spasticity <= 2 on Modified Ashworth Scale (MAS).

6.Patients with <4 on Modified Rankin Scale for disability.

Exclusion Criteria

1.Recurrent strokes

2.Communication Problems

3.Stroke patients with unilateral neglect, apraxia, and agnosia.

4.Post-traumatic hemiplegic patients.

5.Uncontrolled Hypertension

6.cardiac failure, unstable angina, and patient with a respiratory disorder.

7.A sudden worsening condition that prevented the patient from resuming rehabilitative training.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Trunk impairment scale, <br/ ><br>Modified Rankin Scale, <br/ ><br>Stroke Specific Quality of Life Scale, <br/ ><br>10 Meter Walk Test, <br/ ><br>Systolic and Diastolic Blood Pressure, <br/ ><br>Resting Heart Rate and O2 saturation. <br/ ><br>Timepoint: BASELINE, 2ND WEEK, 4TH WEEK, 6TH WEEK
Secondary Outcome Measures
NameTimeMethod
MINI MENTAL STATUS EXAMINATION, MODIFIED ASHWORTH SCALETimepoint: BASELINE, 2ND WEEK, 4TH WEEK, 6TH WEEK
© Copyright 2025. All Rights Reserved by MedPath